Comparative Analysis of Culture Media on J774A.1 Macrophage Function: Exploring Glucose Supplementation and Inflammatory Responses
The J774A.1 murine macrophage cell line, like the RAW 264.7 cell line, is commonly used in inflammation studies and mammalian cell culture. This experiment builds upon prior research examining RAW 264.7 cells by assessing how J774A.1 macrophages respond to different culture media compositions. The standard medium for its growth and maintenance is Dulbecco's Modified Eagle's Medium (DMEM), but in a portion of published work, RPMI 1640, is substituted. RPMI 1640 lacks the high level of glucose present in DMEM (4.5 g/L). The purpose of this work compares J774A.1 cells maintained in DMEM and grown in DMEM or RPMI 1640 prior to experiment. Both media are supplemented with 10% fetal bovine serum, sodium bicarbonate, and 100 IU Penicillin Streptomycin 100μg. DMEM includes 4.5 g/L glucose while RPMI 1640 has a 2 gL glucose concentration. Following a dose response exposure of J774A.1 to a range of 0 ng/mL to 100 ng/mL lipopolysaccharide (LPS) from E. coli (serotype O55:B5) for 24 hours in a 5%CO2/ 37°C environment, nitrite is measured. Cells are maintained in continuous culture with passage every 3 days. Experimentation is carried out on a 24-well plate 500μl volume at 4x10^5 cells per well. After 24-hour exposure to LPS, the Greiss reaction is used to measure nitric oxide response in supernatants. Initial results suggest RAW 264.7 cells grown in RPMI 1640 have a decreased nitric oxide response. The addition of glucose to RPMI 1640 to a 4.5 g/L level did not rescue the nitric oxide response for the J774A.1 cells to a level equivalent to DMEM. This suggests a probable metabolic difference between RAW 264.7 and J774A.1 murine macrophages and further underscores the importance of media composition in and clear standardized culture conditions to ensure experimental consistency and comparison across published work.
Publication Details
- Journal
- Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)
- Published
- 2025-04-16
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00